MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPIVAK, C. E.
Right arrow Articles by TAYLOR, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPIVAK, C. E.
Right arrow Articles by TAYLOR, D. B.

Molecular Pharmacology, Vol 18, 413-420, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Ion Exchange between Agonists and Inorganic Ions at the Acetylcholine Receptor of Torpedo californica

CHARLES E. SPIVAK 1 and DERMOT B. TAYLOR 1

1 Department of Pharmacology and Brain Research Institute, U.C.L.A., School of Medicine, Los Angeles, California 90024

Our objective was to investigate the nature of the reactions by which agonists trigger the nicotinic acetylcholine receptor. A series of experiments on the binding of tritiated decamethonium and muscarone to the particulate-bound nicotinic acetylcholine receptor from Torpedo californica was carried out using a filtration assay. Specific binding was assessed by subtracting the nonspecific binding, found when the receptors were saturated with agr-bungarotoxin, from the total binding. The binding curves obtained by varying the concentration of the physiological ions can be explained by stoichiometric ion-exchange equations, in accordance with the principle of electroneutrality, without invoking positive and negative cooperativity or complicated ad hoc assumptions. In all of our experiments, saturation of the receptors was produced by equimolar quantities of decamethonium, muscarone, and agr-bungarotoxin. These results indicated that an additional anchoring or acceptor site is required to bind decamethonium and that decamethonium is monovalent at the receptor site. The receptor recognition site can change its electrovalence and exchange divalent or monovalent counter ions for either decamethonium or muscarone, depending on the agonist and the ionic environment. In all our experiments the receptor behaved with an electrovalence of either one or two and never with an intermediate value. Using decamethonium and low calcium concentrations (5 mM) the receptor exchanged one decamethonium for one magnesium ion, whereas at higher calcium concentrations (15 mM and above) it exchanged one decamethonium for two monovalent cations. Calcium ions do this by acting on sites other than the agonist recognition site. Similar effects of calcium ions were seen with muscarone. In the divalent state the receptor’s recognition site binds Mg2+ but not Ca2+, and in the monovalent state it binds K+ but not Na+. Attempts to analyze the data in terms of other ionic models were unsuccessful.

Submitted on November 8, 1979
Accepted on June 23, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics